PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Doxycycline 9,324 Drug Target Multidrug Resistance Protein 1 495 2 0.00 -1.00 0.00 0.59
Doxycycline 9,324 Drug Target Cytokeratin 18 1,108 3 0.00 -1.00 0.00 0.59
Angioedema 3,997 Disease Target Eptifibatide 772 1 0.00 -1.00 0.00 0.59
CXCL10 2,386 Target Target CCL8 197 52 0.08 -0.85 0.26 0.77
CXCL10 2,386 Target Target Activin A 2,048 2 0.00 -1.00 0.00 0.60
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
CXCL10 2,386 Target Target CCL1 220 29 0.04 -0.93 0.13 0.75
CXCL10 2,386 Target Target CXCL2 750 83 0.06 -0.93 0.11 0.78
CXCL10 2,386 Target Target CCL21 808 51 0.04 -0.96 0.06 0.75
CXCL10 2,386 Target Target CYR61 539 1 0.00 -1.00 0.00 0.61
CXCL10 2,386 Target Target Cytokeratin 18 1,108 1 0.00 -1.00 0.00 0.59
Glutamate Receptor 1 352 Target Target CXCL2 750 1 0.00 -1.00 0.00 0.65
Kaempferol 2,992 Drug Target BCHE 1,167 4 0.00 -1.00 0.00 0.63
Kaempferol 2,992 Drug Target Multidrug Resistance Protein 1 495 1 0.00 -1.00 0.00 0.60
CCL8 197 Target Target CXCL4/PF4 9 1 0.02 -0.94 0.11 0.75
CCL8 197 Target Target CCL1 220 11 0.05 -0.95 0.06 0.81
CCL8 197 Target Target CXCL2 750 24 0.06 -0.92 0.12 0.79
CCL8 197 Target Target CCL21 808 2 0.01 -0.99 0.01 0.69
CCL8 197 Target Target CYR61 539 1 0.00 -1.00 0.01 0.68
Septic Arthritis 4,121 Disease Target Galectin-1 1,131 1 0.00 -1.00 0.00 0.58
Inflammation 252,734 Disease Target Activin A 2,048 103 0.00 -0.97 0.05 0.58
Inflammation 252,734 Disease Target Equilibrative Nucleoside Transporter 1 211 3 0.00 -0.99 0.01 0.54
Inflammation 252,734 Disease Target Protein Fimh 21 1 0.00 -0.98 0.05 0.55
Inflammation 252,734 Disease Target Galectin-1 1,131 86 0.01 -0.96 0.08 0.59
Inflammation 252,734 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.57
Inflammation 252,734 Disease Target CCL1 220 46 0.01 -0.89 0.21 0.60
Inflammation 252,734 Disease Target CXCL2 750 291 0.02 -0.78 0.39 0.64
Inflammation 252,734 Disease Target BCHE 1,167 14 0.00 -0.99 0.01 0.54
Inflammation 252,734 Disease Target CCL21 808 130 0.01 -0.92 0.16 0.61
Inflammation 252,734 Disease Target CYR61 539 34 0.00 -0.97 0.06 0.58
Inflammation 252,734 Disease Target Eptifibatide 772 15 0.00 -0.99 0.02 0.55
Inflammation 252,734 Disease Target Exodus-3 8 1 0.00 -0.94 0.12 0.57
Inflammation 252,734 Disease Target CD72 198 7 0.00 -0.98 0.04 0.56
Inflammation 252,734 Disease Target aFGF 899 13 0.00 -0.99 0.01 0.54
Inflammation 252,734 Disease Target Multidrug Resistance Protein 1 495 6 0.00 -0.99 0.01 0.53
Inflammation 252,734 Disease Target Sphingosine 1-Phosphate Receptor 1 150 20 0.00 -0.93 0.13 0.59
Inflammation 252,734 Disease Target Signal Transducer And Activator Of Transcription 5b 82 5 0.00 -0.97 0.06 0.56
Inflammation 252,734 Disease Target Cytokeratin 18 1,108 56 0.00 -0.97 0.05 0.58
Activin A 2,048 Target Target CCL21 808 2 0.00 -1.00 0.00 0.63
Activin A 2,048 Target Target CYR61 539 1 0.00 -1.00 0.00 0.61
Activin A 2,048 Target Target aFGF 899 2 0.00 -1.00 0.00 0.63
Activin A 2,048 Target Target Cytokeratin 18 1,108 7 0.00 -1.00 0.01 0.67
Galectin-1 1,131 Target Target CYR61 539 3 0.00 -1.00 0.01 0.67
Galectin-1 1,131 Target Target Multidrug Resistance Protein 1 495 1 0.00 -1.00 0.00 0.63
Doxorubicin 28,033 Drug Target CCL21 808 1 0.00 -1.00 0.00 0.53
Doxorubicin 28,033 Drug Target Eptifibatide 772 1 0.00 -1.00 0.00 0.53
Doxorubicin 28,033 Drug Target aFGF 899 3 0.00 -1.00 0.00 0.56
Doxorubicin 28,033 Drug Target Multidrug Resistance Protein 1 495 50 0.01 -0.95 0.10 0.66
Doxorubicin 28,033 Drug Target Cytokeratin 18 1,108 3 0.00 -1.00 0.00 0.56
Liver Disease 49,817 Disease Target CCL1 220 1 0.00 -1.00 0.00 0.55